Characteristics | CMV-Negative Patients (N = 22) | CMV-Positive Patients (N = 25) | Total Group (N = 47) | P Valuea |
---|---|---|---|---|
Age at the first onset (years) | 32.5 (27.1–37.9) | 31.8 (27.0–36.6) | 32.1 (28.7–35.6) | .975 |
Age at the clinic visit (years) | 36.9 (31.5–42.3) | 39.0 (33.4–44.6) | 38.0 (34.2–41.8) | .654 |
Male gender | 13 (59.1) | 16 (64.0) | 29 (61.7) | .730 |
Bilateral | 2 (9.1) | 3 (12.0) | 5 (10.6) | 1.000 |
Eye involvement | .654 | |||
Right | 12 (54.5) | 12 (48.0) | 24 (51.1) | |
Left | 10 (45.5) | 13 (52.0) | 23 (48.9) | |
Duration of disease (years) | 4.4 (2.4–6.4) | 7.2 (4.5–9.9) | 5.9 (4.2–7.6) | .115 |
< 12 months | 6 (27.3) | 4 (16.0) | 10 (21.3) | |
12–120 months | 12 (54.5) | 16 (64.0) | 28 (59.6) | |
> 120 months | 4 (18.2) | 5 (20.0) | 9 (19.2) |